Follow the ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €177.2m. The latest transaction was filed on 20 May 2026 (Other). Among the most active insiders: Tian Wenzhi. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biopharmaceutical company focused on developing immunological treatments for cancer. It is listed under the H Shares category.